An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative colitis reach clinical remission.
Better Therapeutics lays off staff, considers winding down business
Dive Brief: Better Therapeutics is laying off its employees and looking into strategic alternatives including winding down the business, the digital therapeutic developer said Thursday.